Australasian Science: Australia's authority on science since 1938

Is the end to diabetic injections in sight?

By Richard Maino

Nasal gel reduces blood glucose levels.

The full text of this article can be purchased from Informit.

Globally, it is estimated that diabetes is expected to affect as many as 440 million people by 2030.

But sufferers may never need to take insulin injections again - because innovative scientists working in the United Kingdom have developed a once-a-day nasal gel.

Research by a team led by Dr Hamde Nazar could put an end to numerous daily injections of insulin for type 1 diabetes sufferers, and those type 2 diabetics who also require injections. She is a senior lecturer in pharmacy practice in the Department of Pharmacy, Health & Well-being at the University of Sunderland, north-east England.

Results showed that gel loaded with insulin reduces the blood glucose levels over 24 hours in a diabetic model when administered through the nose and into the bloodstream. When insulin was taken via an injection it took just nine hours for blood glucose to return to normal levels.

Dr Nazar said: “This process could potentially be beneficial because it would reduce the number of injections that patients would have to administer. Some people have to take up to five injections per day. This could replace some of those injections. Reducing the number of insulin injections could significantly improve diabetic patients’ standard of living.”

It is thought that about 300,000 people in the UK suffer from type 1 diabetes that destroys insulin-making cells in...

The full text of this article can be purchased from Informit.